Related Experiment Video

Updated: Mar 26, 2026

Reduction in Left Ventricular Wall Stress and Improvement in Function in Failing Hearts using Algisyl-LVR
07:24

Reduction in Left Ventricular Wall Stress and Improvement in Function in Failing Hearts using Algisyl-LVR

Published on: April 8, 2013

24.8K

[Myocardial revascularisation in patients with reduced left ventricular function]

Volker Schulze, Christian Jung

    Deutsche Medizinische Wochenschrift (1946)
    |February 4, 2016
    PubMed

    Insights

    Myocardial revascularization improves outcomes for patients with heart failure. The decision between percutaneous coronary intervention and bypass surgery requires individual assessment of patient factors and coronary anatomy.

    Area of Science:

    • Cardiology
    • Cardiac Surgery
    • Heart Failure Management

    Context:

    • Myocardial revascularization in patients with reduced left ventricular function presents a complex clinical challenge.
    • Guidelines-guided medical therapy has improved survival rates in these patients.
    • Despite medical therapy, significant mortality and functional impairment persist.

    Purpose:

    • To evaluate the role of myocardial revascularization in improving cardiovascular mortality and functional outcomes in patients with reduced left ventricular function.
    • To provide guidance on the optimal revascularization strategy (percutaneous coronary intervention vs. bypass surgery).

    Summary:

    • Myocardial revascularization, in addition to guideline-directed medical therapy, further reduces cardiovascular mortality and enhances functional outcomes in patients with heart failure and reduced ejection fraction.
    • The choice between percutaneous coronary intervention (PCI) and coronary artery bypass grafting (CABG) should be individualized.
    • Key factors for decision-making include patient comorbidities, coronary artery morphology, and myocardial viability assessment.

    Impact:

    • Optimizing myocardial revascularization strategies can significantly improve survival and quality of life for patients with heart failure.
    • Individualized treatment approaches tailored to patient-specific factors are crucial for successful outcomes.
    • This approach underscores the importance of a multidisciplinary assessment in complex cardiac cases.

    More Related Videos

    Author Spotlight: Enhancing Coronary Artery Revascularization05:25

    Author Spotlight: Enhancing Coronary Artery Revascularization

    Published on: September 15, 2023

    1.4K
    Left Anterior Descending Coronary Artery Ligation for Ischemia-Reperfusion Research: Model Improvement via Technical Modifications and Quality Control05:41

    Left Anterior Descending Coronary Artery Ligation for Ischemia-Reperfusion Research: Model Improvement via Technical Modifications and Quality Control

    Published on: December 16, 2022

    4.7K

    Related Concept Videos

    Cardiomyopathy V: Interprofessional Care01:29

    Cardiomyopathy V: Interprofessional Care

    Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
    621
    Aortic Regurgitation III: Medical Management01:25

    Aortic Regurgitation III: Medical Management

    Aortic regurgitation (AR) is when the aortic valve does not close or seal properly, leading to backward blood circulation from the aorta into the left ventricle during diastole. Common causes of AR include rheumatic heart disease, congenital valve defects, and aortic root dilation. Managing AR requires a multifaceted approach to alleviate symptoms, preserve left ventricular function, and address the underlying cause of the regurgitation. Patients with symptomatic AR or significant left...
    547
    Myocarditis III: Medical Management01:14

    Myocarditis III: Medical Management

    Myocarditis: Comprehensive Medical ManagementMyocarditis, the heart muscle inflammation, requires a comprehensive medical management strategy that addresses the underlying cause, provides supportive care, manages symptoms, and reduces cardiac workload.Infections and Autoimmune CausesAdminister appropriate antimicrobial therapy when an infectious agent causes myocarditis. For instance, penicillin treats infections caused by Group A Streptococcus. In cases where autoimmune processes are...
    314
    Cardiomyopathy II: Dilated Cardiomyopathy01:30

    Cardiomyopathy II: Dilated Cardiomyopathy

    Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
    743
    Mitral Regurgitation III: Medical Management01:25

    Mitral Regurgitation III: Medical Management

    Mitral regurgitation (MR) is characterized by retrograde blood circulation from the left ventricle into the left atrium due to inadequate mitral valve closure. The severity of the condition, symptoms, and underlying cause determine treatment strategies.Monitoring and Pharmacological TreatmentPatients with mild to moderate MR typically do not need immediate intervention but regular monitoring to assess progression and guide treatment. Patients with mild MR should have an echocardiogram every 3-5...
    556
    Cardiomyopathy IV: Restrictive Cardiomyopathy01:29

    Cardiomyopathy IV: Restrictive Cardiomyopathy

    Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...
    781